AMG Completes Investment in Forbion
17 Agosto 2023 - 9:00AM
Affiliated Managers Group, Inc. (NYSE: AMG), a leading partner to
independent investment management firms globally, today announced
the completion of its investment in Forbion Group Holding B.V.
(“Forbion”).
Forbion is a leading pan-European venture capital and growth
equity firm focused on investing in high-quality life sciences
companies across all stages of their development. With
approximately €3 billion in assets under management, Forbion
provides capital and expertise to life sciences companies, enabling
the development of new therapeutics that can impact the future of
medicine. Led by co-founders and Managing Partners Sander Slootweg,
Geert-Jan Mulder, and Martien van Osch, Forbion’s seasoned team has
delivered excellent returns for clients across more than two
decades, and continues to support companies delivering breakthrough
drug therapies to the global market.
The terms of the transaction were not disclosed.
About AMG
AMG is a leading partner to independent investment management
firms globally. AMG’s strategy is to generate long-term value by
investing in a diverse array of high-quality independent
partner-owned firms, through a proven partnership approach, and
allocating resources across AMG’s unique opportunity set to the
areas of highest growth and return. AMG’s innovative partnership
approach enables each Affiliate’s management team to own
significant equity in their firm while maintaining operational and
investment autonomy. In addition, AMG offers its Affiliates growth
capital, distribution, and other strategic value-added
capabilities, which enhance the long-term growth of these
independent businesses, and enable them to align equity incentives
across generations of principals to build enduring franchises. As
of June 30, 2023, AMG’s aggregate assets under management were
approximately $674 billion across a broad range of differentiated
investment strategies. For more information, please visit the
Company’s website at www.amg.com
About Forbion
Forbion is a dedicated life sciences venture capital firm with
offices in The Netherlands, Germany, and Singapore. Forbion invests
in life sciences companies that are active in the biopharmaceutical
space, managing €3 billion across multiple fund strategies that
cover all stages of biopharmaceutical drug development. The firm’s
current team consists of more than 30 life sciences investment
professionals that have built an impressive performance track
record since the late nineties with investments in 95 companies
across 8 funds. Forbion’s record of sourcing, building and guiding
life sciences companies has resulted in many breakthrough therapies
and valuable exits. In addition to its financial return objectives,
Forbion selects investments that will positively affect the health
and well-being of patients. The firm is a signatory to the United
Nations Principles for Responsible Investment. More information can
be found at www.forbion.com
Certain matters discussed in this press release may constitute
forward-looking statements within the meaning of the federal
securities laws, and could be impacted by a number of factors,
including those described under the section entitled “Risk Factors”
in AMG’s most recent Annual Report on Form 10-K, as such factors
may be updated from time to time in the Company’s periodic filings
with the SEC, which are accessible on the SEC's website at
www.sec.gov. AMG undertakes no obligation to publicly update or
review any forward-looking statements, whether as a result of new
information, future developments or otherwise, except as required
by applicable law. From time to time, AMG may use its website as a
distribution channel of material Company information. AMG routinely
posts financial and other important information regarding the
Company in the Investor Relations section of its website at
www.amg.com and encourages investors to consult that section
regularly.
AMG Investor Relations: Patricia Figueroa
AMG Media Relations: Ann Imes
(617) 747-3300ir@amg.compr@amg.com
Affiliated Managers (NYSE:AMG)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Affiliated Managers (NYSE:AMG)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024